Brief: Oncoarendi Therapeutics FY 2021 Net Result Turns To Loss Of 13.6 Mln Zlotys
24/03/2022 16:38
March 24 (Reuters) - Oncoarendi Therapeutics SA OAT.WA :
* FY 2021 NET LOSS OF 13.6 MILLION ZLOTYS VERSUS PROFIT 68.0
MILLION ZLOTYS YEAR AGO
* FY 2021 OPERATING REVENUE 1.5 MILLION ZLOTYS VERSUS 124.9
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM1rtcHya
Further company coverage: OAT.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments